Macrophage Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
C. J. Halbrook, C. Pontious, H.-J. Lee, I. Kovalenko, Y. Zhang, L. Lapienyte, S. Dreyer, D. M. Kremer, P. Sajjakulnukit, L. Zhang, B. Nelson, H. Hong, S. Kemp, D. Chang, A. Biankin, , C. A. Lyssiotis
This study shows macrophages in pancreatic cancer release pyrimidines that inhibit gemcitabine therapy by competing with the drug for uptake and metabolism, and reducing macrophage burden improves treatment response.
bioRxiv · Nov 5, 2018Cancer Biology